V V Kakkar. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Clinical Trials as TopicDihydroergotamine/therapeutic useDrug Therapy, CombinationForecastingHemorrhage/chemically inducedHeparin/administration & dosageHeparin/adverse effectsHeparin/analogs & derivativesHumansPostoperative Complications/prevention & controlPulmonary Embolism/prevention & controlThrombophlebitis/prevention & control
Substances: See more » DihydroergotamineHeparin
Year: 1980 PMID: 7006053 DOI: 10.1111/j.1600-0609.1980.tb02523.x
Source DB: PubMed Journal: Scand J Haematol Suppl ISSN: 0080-6722